Literaturverzeichnis

Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL (1992). IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol.;148:3820-3829.

Aboalchamat B, Engelmann K, Böhnke M, Eggli P, Bednarz J (1999). Morphological and functional analysis of immortalized human corneal endothelial cells after transplantation. Exp Eye Res.; 69:547-553.

Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC (1986). Human basic fibroblast growth factor: nucleotide sequence and genomic organization . EMBO J.;5:2523-2528.

Abraham NG, da Silva JL, Lavrovsky Y, Stoltz RA, Kappas A, Dunn MW, Schwartzman ML (1995). Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci.;36:2202-2210.

Abul-Hassan K, Walmsley R, Boulton M (2000). Optimization of non-viral gene transfer to human primary retinal pigment epithelial cells. Curr Eye Res.; 20:361-366.

Albon J, Tullo AB, Aktar S, Boulton ME (2000). Apoptosis in the endothelium of human corneas for transplantation. Invest Ophthalmol Vis Sci.;41:2887-2893.

Alldredge OC, Krachmer JH (1981). Clinical types of corneal transplant rejection. Their manifestations, frequency, preoperative correlates, and treatment. Arch Ophthalmol.;99:599-604.

Arancibia-Cárcamo CV, Oral HB, Haskard DO, Larkin DF, George AJ (1998). Lipoadenofection-mediated gene delivery to the corneal endothelium. Transplantation.;65:62-67.

Assouline M, Hutchinson C, Morton K, Mascarelli F, Jeanny JC, Fayein N, Pouliquen Y, Courtois Y (1989). In vivo binding of topically applied human bFGF on rabbit corneal epithelial wound. Growth Factors.;1:251-261.

Bednarz J, Teifel M, Friedl P, Engelmann K (2000). Immortalization of human corneal endothelial cells using electroporation protocol optimised for human corneal endothelial and human retinal pigment epithelial cells. Acta Ophthalmol Scand.;78:130-136.

Behr JP, Demeneix B, Loeffler JP, Perez-Mutul J (1989). Efficient gene transfer in mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA.;86:6982-6986.

Belting M, Petersson P (1999). Protective role for proteoglycan against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro. Biochem J.; 342:281-286.

Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science.;275:1320-1323.

Blair-Parks K, Weston BC, Dean DA (2002). High-level gene transfer to the cornea using electroporation. J Gene Med.;4:92-100.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Narula SK, Smith SR, Roncarolo MG, Vallera DA (1998). Interleukin-10 dose-dependent regulation of CD4+ and CD8+ T cell-mediated graft-versus-host disease. Transplantation.;66:1220-1229.

Boisgerault F, Liu Y, Anosova N, Ehrlich E, Dana MR, Benichou G (2001). Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol.;167:1891-1899.

Borras T, Tamm ER, Zigler Jr.JS (1996). Ocular adenovirus gene transfer varies in efficiancy and inflammatory response. Invest Ophthalmol Vis Sci.;37:1282-1293.

Bourne WM, Nelson LR, Hodge DO (1997). Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci.;38:779-782.

Brandt C (2003). Retroviral modifizierte, alloantigen-spezifische und vIL-10 transgene T-Lymphozyten als therapeutischer Ansatz im akuten Abstoßungsmodell. Dissertation.

Bron AJ, Tripathi DM, Tripathi BJ (1997). Wolff’s anatomy of the eye and orbit, 8th edition. Chapman & Hall Medical, London.

Budenz DL, Bennett J, Alonso L, Maguire A (1995). In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci.;36:2211-2215.

Callanan D, Peeler J, Niederkorn JY (1988). Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation.;45:437-443.

Caruelle D, Groux-Muscatelli B, Gaudric A, Sestier C, Coscas G, Caruelle JP, Barritault D. (1989). Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J Cell Biochem.;39:117-128.

Chen R, Greene EL, Collinsworth G, Grewal JS, Houghton O, Zeng H, Garnovskaya M, Paul RV, Raymond JR. (1999). Enrichment of transiently transfected mesengial cells by cell sorting after cotransfection with GFP. Am J Physiol.;276:F777-F785.

Chomarat P, Banchereau J (1997). An update on interleukin-4 and its receptor. Eur Cytokine Netw.;8:333-344.

Claerhout I (2004). Role of NK cells in rat corneal allograft rejection. Transplantation.; in press.

Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF (2002). Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci.;43:1095-1103. Erratum in: Invest Ophthalmol Vis Sci;43:1701.

Coupland SE, Krause L, Karow AC, Bartlett RR, Lehmann M, Hoffmann F (1995). Delay in corneal allograft rejection due to anti-CD4 antibody given alone and in combination with cyclosporin A and leflunomide. Ger J Ophthalmol.;4:294-301.

Cua DJ, Coffman RL, Stohlman SA (1996 ). Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J Immunol.;157:2830-2836.

Dabin I, Courtois Y (1991). Acidic fibroblast growth factor overexpression in corneal epithelial wound healing. Growth Factors.;5:129-139.

Dallman MJ, Larsen CP, Morris PJ (1991). Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med.;174:493-497.

Dallman MJ (1993). Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol.;5:788-793.

Dana MR, Yamada J, Streilein JW (1997). Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation.;63:1501-1507.

David A, Chetritt J, Coupel-Clauce H, Tesson L, Cassard A, Blancho G et al (1997). Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis. Cytokine.;9:818-829.

David A Coupel-Clauce H, Chetritt J, Tesson L, Cassard A, Charreau B, Soulillou JP, Anegon I. (1998). Anti-adenovirus immune responses in rats are enhanced by interleukin-4 but not interleukin-10 produced by recombinant adenovirus. Hum Gene Ther.;9:1755-1768.

David A, Chetritt J, Guillot C, Tesson L, Heslan JM, Cuturi MC, Soulillou JP, Anegon I (2000). Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther.;7:505-510.

deVries JE (1995). Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med.;27:537-541.

deWaal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, deVries JE (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med.;174:915-924.

deWaal Malefyt R, Moore KW (1998). Interleukin-10. In Angus T (ed.) The cytokine handbook. Academic press: London pp333-364.

Doebis C, Ritter T, Brandt C, Schonberger B, Volk HD, Seifert M (2002). Efficient in vitro transduction of epithelial cells and keratinocytes with improved adenoviral gene transfer for the application in skin tissue engineering. Transpl Immunol.;9:323-329.

EBAA (2002). Eye bank association of amerika. www.restoresight.org

Efrat S, Fejer G, Brownlee M, Horwitz MS (1995). Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci U S A.;92:6947-6951.

Efrat S, Serreze D, Svetlanov A, Post CM, Johnson EA, Herold K, Horwitz M (2001). Adenovirus early region 3(E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes.;50:980-984.

Engelmann K, Böhnke M (1990). Human corneal endothelial cells in long-term cultures: The influence of conditions for isolation, selective and normal growth, and the extracellular matrix on proliferation and morphology. Chibret Int J Ophthalmol.;7:3-13.

Engelmann K, Bednarz J, Böhnke M (1999). Endothelial cell transplantation and growth behavior of the human corneal endothelium. Ophthalmologe.;96:555-562.

Esch F, Ueno N, Baird F, Hill F, Denoroy L, Ling N, Gospodarowicz D, Guillemin R (1985). Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochem Biophys Res Commun.;133:554-562.

Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ (1996). Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther.;7:215-222.

Farhood H, Serbina N, Huang L (1995). The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer.Biochim Biophys Acta.;1235:289-295.

Fehervari Z, Rayner SA, Oral HB, George AJ, Larkin DF (1997). Gene transfer to ex vivo stored corneas. Cornea.;16:459-464.

Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem.;269:2550-2561.

Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991 ). IL-10 inhibits cytokine production by activated macrophages. J Immunol.;147:3815-3822.

Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol.;146:3444-3451.

Frueh BE, Böhnke M (1995). Corneal grafting of donor tissue preserved for longer than 4 weeks in organ-culture medium. Cornea.;14:463-466.

Gain P, Thuret G, Chiquet C, Dumollard JM, Mosnier JF, Campos L (2001). In situ immunohistochemical study of Bcl-2 and heat shock proteins in human corneal endothelial cells during corneal storage. Br J Ophthalmol.;85:996-1000.

Gajewski TF, Fitch FW (1988). Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol.;140:4245-4252.

George AJ, Arancibia-Carcamo CV, Awad HM, Comer RM, Fehevari Z, King WJ, Kadifachi M, Hudde T, Kerouedan-Lebosse C, Mirza F, Barbaros Oral H, Rayner SA, Tan PH, Tay E, Larkin DF (2000). Gene delivery to the corneal endothelium . Am J Respir Crit Care Med.;162:194-200.

Gill TJ, Kunz HW, Misra DN, Hassett ALC (1987). The major histocompatibility complex of the rat. Transplantation.;43:773-785.

Goerdt S, Orfanos CE (1999). Other functions, other genes: alternative activation of antigen-presenting cells. Immunity.;10:137-142.

Gore SM, Vail A, Bradley BA, Rogers CA, Easty DL, Armitage WJ (1995). HLA-DR matching in corneal transplantation. Systematic review of published evidence. Corneal Transplant Follow-up Study Collaborators. Transplantation.;60:1033-1039.

Gospodarowicz D, Mescher AL, Birdwell CR (1977). Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors. Exp Eye Res.;25:75-89.

Gospodarowicz D, Greenburg G ( 1979). The effects of epidermal and fibroblast growth factors on the repair of corneal endothelial wounds in bovine corneas maintained in organ culture. Exp Eye Res.;28:147-157.

Gospodarowicz D, Neufeld G, Schweigerer L (1986). Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ.;19:1-17.

Graham FL, Smiley J, Russell WC, Nairn R (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol.;36:59-74.

Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995). Fas-ligand-induced apoptosis as a mechanism of immune privilege. Science.;270:1189-1192.

Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature.;389:737-742.

Guillot C, David A, Coathalem H, Froud D, Tesson L, Moullier P, Le Mauff B, Usal C, Soulillou JP, Cuturi MC, Anegon I (1999). Adenovirus-mediated cytokine gene transfer in heart allograft transplantation. Biochem Soc Trans.;27:864-869.

Haskova Z, Usiu N, Pepose JS, Ferguson TA, Stuart PM (2000). CD4+ T cells are critical for corneal, but not skin, allograft rejection. Transplantation.;69:483-487.

Hawley-Nelson P, Ciccaroni V, Gebeyehu G, Jessee J (1993). Lipofectamine reagent: a new, higher efficiency polycationic liposome transfection reagent. Focus.;15:73-79.

He YG, Ross J, Niederkorn JY (1991). Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci.;32:2723-2728.

He XY, Chen J, Verma N, Plain K, Tran G, Hall BM (1998). Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses. Transplantation.;65:1145-1152.

Hedge S, Niederkorn JY (2000). The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci.;41:3341-3347.

Holland EJ, Chan CC, Wetzig RP, Palestine AG, Nussenblatt RB (1991). Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model. Cornea.;10:374-380.

Hoppenreijs VP, Pels E, Vrensen GF, Treffers WF (1994). Basic fibroblast growth factor stimulates corneal endothelial cell growth and endothelial wound healing of human corneas. Invest Ophthalmol Vis Sci.;35:931-944.

Horwitz MS (1990 ). Adenoviridae and their replication. In Virology. B.N. Fields and D.M. Knipe, editors. Raven Press, New York. 1679-1721.

Houssaint E, Blanquet PR, Champion-Arnaud P, Gesnel MC, Torriglia A, Courtois Y, Breathnach R (1990). Related fibroblast growth factor receptor genes exist in the human genome. Proc Natl Acad Sci USA.;87:8180-8184.

Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR (1996). Adenovirus interaction with distinct integrins mediates seperate events in cell entry and gene delivery to hematopoietic cells. J Virol.;7:4502-4505.

Imamura T, Engleka K, Zhan X, Tokita Y, Forough R, Roeder D, Jackson A, Maier JA, Hla T, Maciag T (1990). Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science.;249:1567-1570.

Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T (1992). Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc Natl Acad Sci U S A.;89:10691-10695.

Jaye M, Howk R, Burgess W, Ricca GA, Chiu IM, Ravera MW, O'Brien SJ, Modi WS, Maciag T, Drohan WN (1986). Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science.;233:541-545.

Joo CK, Pepose JS, Stuart PM (1995). T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci.;36:1530-1540.

Josien R, Muschen M, Gilbert E, Douillard P, Heslan JM, Soulillou JP, Cuturi MC (1998). Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation.;66:887-893.

Joyce NC (2003). Proliferative capacity of the corneal endothelium. Prog Ret Eye Res.;22:359-389.

Kato H, Fieblinger C, Ke B, Li J, Volk HD, Busuttil RW, Kupiec-Weglinski JW, Ritter T (1999). Synergistic effects of cytokine gene transfer in high responder rat renal allograft recipients. (Abstract) Transplantation, 67:570.

Kato H, Ritter T, Murakami M, Kusano M, Busuttil RW, Kupiec-Weglinski JW (2000). Adenovirus-mediated gene transfer of IL-4 prolongs rat renal allograft survival and inhibits the p21ras-activation pathway. Transpl Proceed.,32:245-246.

Kay MA, Glorioso JC, Naldini L (2001 ). Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med.;7:2133-2140.

Ke B, Ritter T, Kato H, Zhai Y, Li J, Lehmann M, Busuttil RW, Volk HD, Kupiec-Weglinski JW (2000). Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol.;164 :5739-5745.

Ke B, Buelow R, Shen XD, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW, Kupiec-Weglinski JW (2002). Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther.;13 :1189-1199.

Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH (1994 ). Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones.Eur J Immunol.;24 :2271-2278.

King WJ, Comer RM, Hudde T, Larkin DF, George AJ (2000). Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation.;70:1225-1233.

Klebe S, Sykes PJ, Coster DJ, Krishnan R, Williams KA (2001). Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation.;71: 1214-1220.

Kolls J, Peppel K, Silva M, Beutler B (1994). Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci U S A.;91:215-219.

Landshman N, Belkin M, Ben-Hanan I, Ben-Chaim O, Assia E, Savion N (1987). Regeneration of cat corneal endothelium induced in vivo by fibroblast growth factor. Exp Eye Res.;45: 805-811.

Larkin DFP (1994). Corneal allograft rejection. Br J Ophthalmol.;78:649-652.

Larkin DF, Oral HB, Ring CJ, Lemoine NR, George AJ (1996). Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation.;613: 363-370.

Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX, Wan NC, Scheule RK, Harris DJ, Smith AE, Cheng SH (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther.;7:1701-1717.

Li S, Rizzo MA, Bhattacharya S, Huang L (1998). Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther.;5: 930-937.

Lovicu FJ, de Iongh RU, McAvoy JW (1997). Expression of FGF-1 and FGF-2 mRNA during lens morphogenesis, differentiation and growth. Curr Eye Res.;16:222-230.

Ma Y, Hurst HE, Fernandez-Botran R (1996). Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4. J Pharmacol Exp Ther.;279:340-350.

Mascarelli F, Fuhrmann G, Courtois Y (1993). aFGF binding to low and high affinity receptors induces both aFGF and aFGF receptor dimerization. Growth Factors.;8:211-233.

Mignatti P, Morimoto T, Rifkin DB (1992). Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol.;151: 81-93.

Modrow S, Falke D (1997). Molekulare Virologie. Spektrum Akademischer Verlag GmbH Heidelberg, Berlin, Oxford, 391-406.

Mosmann TR, Coffman RL (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol.;7:145-173.

Mottram PL, Han WR, Purcell LJ, McKenzie IF, Hancock WW (1995). Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation.;59: 559-565.

Mueller R, Davies JD, Krahl T, Sarvetnick N (1997). IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. J Immunol.; 159:1599-1603.

Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ (1993). Recombinant fibroblast growth factor–1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature.;362:844-846.

Nelson D, Cox M (2001). Lehninger Biochemie. 3. Auflage, Springer-Verlag Berlin, Heidelberg, New York.

Nickerson P, Pacheco-Silva A, O'Connell PJ, Steurer W, Kelley VR, Strom TB (1993). Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transplant Proc.;25:984-985.

Nickerson P, Steiger J, Zheng XX, Steele AW, Steurer W, Roy-Chaudhury P, Strom TB (1997). Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation.;63:489-494.

Niederkorn JY ( 1999) . Anterior chamber associated immune deviation. Chem Immunol.;73: 59-71.

Nishi Y, Hosokawa T, Aoike A, Kawai K, Kamahora T (1990). Early development of CD8-negative and CD8-positive MHC-unrestricted cytotoxic cells induced by alloantigen inoculation in mice. Microbiol Immunol.;34:775-785.

Nunez R, Ackermann M, Saeki Y, Chiocca A, Fraefel C (2001). Flow cytometric assessment of transduction efficiency and cytotoxicity of Herpes simplex virus type 1-based amplicon vectors. Cytometry.;44:93-99.

Olive M, Eisenlohr L, Flomenberg N, Hsu S, Flomenberg P (2002). The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. Hum Gene Ther.;13: 1167-1178.

Oral HB, Larkin DFP, Fehervari Z, Byrnes AP, Rankin AM, Haskard DO, Wood MJ, Dallman MJ, George AJ (1997). Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther.;4 :639-647.

Ornitz D, Yayon A, Flanagan J, Svann C, Levi E, Leder P (1992). Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and mitogenesis in whole cells. Mol Cell Biol.;12:240-247.

Ornitz DM (2000). FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays.;22: 108-112.

Oshima Y, Sakamoto T, Hisatomi T, Tsutsumi C, Sassa Y, Ishibashi T, Inomata H (2002). Targeted gene transfer to corneal stroma in vivo by electric pulses. Exp Eye Res.;74:191-198.

Paul WE (1991). Interleukin-4: a prototypic immunoregulatory lymphokine. Blood.;77:1859-1870.

Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK (1997). Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation.;63:619-624.

Pleyer U, Steuhl KP, Weidle EG, Lisch W, Thiel HJ (1992). Corneal graft rejection: incidence, manifestation, and interaction of clinical subtypes. Transplant Proc.;24:2034-2037.

Pleyer U, Milani JK, Dukes A, Chou J, Lutz S, Ruckert D, Thiel HJ, Mondino BJ (1995). Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci.;36:52-61.

Pleyer U und Thiel HJ (1995). Cytotoxic mechanisms in corneal allograft rejection. In: Pleyer U, Schmidt KH, Thiel HJ (Eds.) Cell and tissue protection in ophthalmology. Thieme/Hippokrates, Stuttgart, pp:71-82.

Pleyer U, Rieck P, Ritter T, Hartmann C (1998). Immune reaction after penetrating keratoplasty. II. Prevention and therapy. Ophthalmologe.;95: 444-459.

Pleyer U, Bertelmann E, Rieck P, Hartmann C, Volk HD, Ritter T (2000). Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4. Graefe’s Arch Clin Exp Ophthalmol, 238:531-536.

Pleyer U, Dannowski H, Volk HD, Ritter T (2001a). Corneal allograft rejection: current understanding. I. Immunobiology and basic mechanisms. Ophthalmologica.;215:254-62.

Pleyer U, Groth D, Hinz B, Keil O, Bertelmann E, Rieck P, Reszka R (2001b). Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells. Exp Eye Res.;73: 1-7.

Pleyer U, Dannowski H (2002). Delivery of genes via liposomes to corneal endothelial cells. Drug News Perspect.;15:283-289.

Pleyer U, Ritter T (2003). Gene therapy in immune-mediated diseases of the eye. ProgRetin Eye Res.;22: 277-293.

Powrie F, Menon S, Coffman RL (1993 ). Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol.;23:2223-2229.

Qian Y, Dana MR (2001). Molecular mechanism of immunity in corneal allotransplantation and xenotransplantation. Expert Rev Mol Med.;3:1-21.

Qin L, Chavin KD, Ding Y, Favaro JP, Woodward JE, Lin J, Tahara H, Robbins P, Shaked A, Ho DY, et al. (1995). Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation.;59:809-816.

Qin L, Ding Y, Pahud DR, Robson ND, Shaked A, Bromberg JS (1997a). Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther.;8:1365-1374.

Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS (1997b). Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther.;8: 2019-2029.

Rayner SA, Larkin DFP, George AJT (2001). TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest Ophthalmol Vis Sci.;42:1568-1573.

Redbrake C, Salla S, Frantz A, Reim M (1999). Metabolic changes of the human donor cornea during organ-culture. Acta Ophthalmol Scand.;77:266-272.

Regelin AE, Fankhaenel S, Gürtesch L, Prinz C, von Kiedrowski G, Massing U (2000 ). Biophysical and lipofection studies of DOTAP analogs. Biochim Biophys Acta.;1464: 151-164.

Reinhard T, Hutmacher M, Sundmacher R (1997). Acute and chronic immune reactions after penetrating keratoplasty with normal immune risk. Klin Monatsbl Augenheilkd.;210:139-143.

Rieck P, Oliver L, Engelmann K, Fuhrmann G, Hartmann C, Courtois Y (1995). The role of exogenous/endogenous basic fibroblast growth factor (FGF2) and transforming growth factor ß (TGF-ß1) on human corneal endothelial cell proliferation in vitro. Exp Cell Res.;220:36-46.

Rieck PW, Gigon M, Jaroszewski J, Pleyer U, Hartmann C (2003 ). Increased endothelial survival of organ-cultured corneas stored in FGF-2-supplemented serum-free medium. Invest Ophthalmol Vis Sci.;44 :3826-3832.

Rinne JR, Stulting RD (1992). Current practices in the prevention and treatment of corneal graft rejection. Cornea.;11: 326-328.

Ritter T, Vogt K, Rieck P, Schilling-Schön A, Kolls J, Hartmann C, Volk HD, Pleyer U (1999a). Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res.;69:563-568.

Ritter T, Risch K, Schroder G, Kolls J, Siegling A, Graser E, Reinke P, Brock J, Lehmann M, Volk HD (1999b). Intragraft overexpression of interleukin-4 is neither sufficient nor essential for tolerance induction to cardiac allografts in a high-responder strain combination. Transplantation.;68:1427-1431.

Ritter T, Brandt C, Prosch S, Vergopoulos A, Vogt K, Kolls J, Volk HD (2000). Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells. Cytokine.;12:1163-1170.

Ritter T, Lehmann M, Volk HD (2002). Improvements in gene therapy: averting the immune response to adenoviral vectors. Bio Drugs.;16:3-10.

Ritter T (2003). Anti-inflammatorische und zytoprotektive Gentherapie am Beispiel der experimentellen Transplantation. Habilitationsschrift.

Sanger F, Nicklen S, Coulson AR (1977). DNA-sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA.;74:5463-5467.

Sano Y, Osawa H, Sotozono C, Kinoshita S (1998). Cytokine expression during orthotopic corneal allograft rejection in mice. Invest Ophthalmol Vis Sci.;39:1953-1957.

Sawitzki B, Amersi F, Ritter T, Fisser M, Shen XD, Ke B, Busuttil R, Volk HD, Kupiec-Weglinski JW (2002). Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther.;13:1495-1504.

Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA (1995). CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med.;181:1869-1874.

Schilling-Schön A, Pleyer U, Hartmann C, Rieck PW (2000). The role of endogenous growth factors to support corneal endothelial migration after wounding in vitro. Exp Eye Res.;71:583-589.

Schmidt N (2004). Immunhistologische Untersuchung von infiltrierenden Zellen nach adenoviraler vIL-10-Transduktion in der experimentellen Keratoplastik.(Dissertation in Vorbereitung).

Slegers TP, Torres PF, Broersma L, van Rooijen N, van Rij G, van der Gaag R (2000). Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats. Invest Ophthalmol Vis Sci.; 41:2239-2247.

Slegers TP, van der Gaag R, van Rooijen N, van Rij G, Streilein JW (2003). Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts. Curr Eye Res.;26: 73-79.

Smith DK, Korbutt GS, Suarez-Pinzon WL, Kao D, Rajotte RV, Elliott JF (1997). Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation.; 64:1040-1049.

Sorgi FL, Bhattacharya S, Huang L (1997). Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther.;4:961-968.

Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB (1995). IL-2 knockout recipient mice reject islet cell allografts.J Immunol.;155:489-498.

Stein J, Volk HD, Liebenthal C, Kruger DH, Prosch S (1993). Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol.;74:2333-2338.

Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997). CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest.;99:396-402.

Stübiger N, Pleyer U, Erb C, Thiel HJ (1995). Keratoplasty a chaud. Ophthalmologe.;92:427-432.

Sung RS, Qin L, Bromberg JS (2001). TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol Ther.;3:757-767.

Swain SL (1995). CD4 T cell development and cytokine polarization: an overview. J Leukoc Biol.;57:795-798.

Takeuchi T, Lowry RP, Konieczny B (1992). Heart grafts in murine systems: the differential activation of Th2-like effectors in peripheral tolerance. Transplantation.;53:1281-1294.

Takeuchi T, Ueki T, Sunaga S, Ikuta K, Sasaki Y, Li B, Moriyama N, Miyazaki JI, Kawabe K (1997). Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the TH1 cytokine mRNA in grafts. Transplantation.;64:152-157.

Tan PH, King WJ, Chen D, Awad HM, Mackett M, Lechler RI, Larkin DFP, George AJT (2001). Transferrin receptor-mediated gene trasfer to the corneal endothelium. Transplantation.;74 :552-560.

Tan PH, Manunta M, Ardomand N, Xue SA, Larkin DF, Haskard D, Taylor KM, George AJ (2003). Antibody targeted gene transfer to endothelium.J Gene Med.;5: 311-323.

Thanh HN, Murakami A, Fujiki K, Kanai A (2002). Transferrin-Polyethylenimine conjugate, Fugene6 and Transit-LT as non-viral vectors for gene transfer to the corneal endothelium. Jpn J Ophthalmol.;46:140-146.

Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995). Global data on blindness. Bull World Health Organ.;73:115-121.

Torres PF, de Vos AF, van der Gaag R, Martins B, Kijlstra A (1996). Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res.;63: 453-461.

Torres PF, de Vos AF, Martins B, Kijlstra A (1999). Interleukin 10 treatment does not prolong experimental corneal allograft survival. Ophthalmic Res.;31:297-303.

Uchida E, Mizuguchi H, Ishii-Watabe A, Hayakawa T (2002). Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells. Biol Pharm Bull.;25: 891-897.

Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitage WJ (1994). Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation.;58:1210-1216.

Verma IM, Somia N (1997). Gene therapy -- promises, problems and prospects. Nature.;389:239-242.

Wackenheim-Urlacher A, Kantelip B, Falkenrodt A, Piqot X, Tongio MM, Montard M, Delbosc B (1995). T-cell repertoire of normal, rejected, and pathological corneas: phenotype and function. Cornea.;14:450-456.

Wiedlocha A, Falnes PO, Rapak A, Munoz R, Klingenberg O, Olsnes S (1996). Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization. Mol Cell Biol.;16:270-280.

Williams KA, Coster DJ (1997). Rethinking immunological privilege: implications for corneal and limbal stem cell transplantation. Mol Med Today.;3: 495-501.

Wilson SE, Schultz GS, Chegini N, Weng J, He YG (1994). Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res.;59:63-72.

Wold WS, Gooding LR (1991). Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology.;184:1-8.

Xu Y, Szoka FC Jr. (1996). Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry.;35:5616-5623.

Yamada J, Yoshida M, Taylor AW, Streilein JW (1999). Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in high risk eyes. J Immunol.;162: 5247-5255.

Yamada J, Ksander BR, Streilein JW (2001). Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci.;42: 386-392.

Yamagami S, Kawashima H, Tsuru T, Yamagami H, Kayagaki N, Yagita H, Okumura K, Gregerson DS (1997). Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation.;64: 1107-1111.

Yamagami S, Kawashima H, Endo H, Tsuru T, Shibui H, Kagawa Y, Hori J, Yamagami H, Isobe M (1998). Cytokine profiles of aqueous humor and graft in orthotopic mouse corneal transplantation. Transplantation.;66: 1504-1510.

Yang J, Reutzel-Selke A, Steier C, Jurisch A, Tullius SG, Sawitzki B, Kolls J, Volk HD, Ritter T (2003). Targeting of macrophage activity by adenovirus-mediated intragraft overexpression of TNFRp55-Ig, IL-12p40, and vIL-10 ameliorates adenovirus-mediated chronic graft injury, whereas stimulation of macrophages by overexpression of IFN-gamma accelerates chronic graft injury in a rat renal allograft model. J Am Soc Nephrol.;14:214-225.

Yang J, Pleyer U, Dannowski H, Vogt K, Hempel M, Volk HD, Ritter T (2004). Effects of local interleukin-12p40 gene therapy on rat corneal allograft survival. (zur Veröffentlichung eingereicht).

Yang Y, Ertl HCJ, Wilson J (1994). MHC class-I restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infectedet with E1-deleted recombinant adenovirus.Immunity.;1:433-442.

Zabner J, Fasbender AJ, Moninger T, Poellinger KA, Welsh MJ (1995). Cellular and molecular barriers to gene transfer by a cationic lipid.J Biol Chem.;270:18997-19007.

Zhan X, Hu X, Friedman S, Maciag T (1992). Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells. Biochem Biophys Res Commun.;188: 982-991.

Zhou XH, Huang L ( 1994). DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim Biophys Acta.;1189:195-203.

Zuo Z, Wang C, Carpenter D, Okada Y, Nicolaidou E, Toyoda M, Trento A, Jordan SC (2001). Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation.;71:686-691.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
29.11.2004